Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Te-Hui Chou"'
Autor:
Shixia Wang, Te-hui Chou, Anthony Hackett, Veronica Efros, Yan Wang, Dong Han, Aaron Wallace, Yuxin Chen, Guangnan Hu, Shuying Liu, Paul Clapham, James Arthos, David Montefiori, Shan Lu
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 12, Pp 2996-3009 (2017)
Our previous preclinical studies and a Phase I clinical trial DP6-001 have indicated that a polyvalent Env formulation was able to elicit broadly reactive antibody responses including low titer neutralizing antibody responses against viral isolates o
Externí odkaz:
https://doaj.org/article/4830e188ee414344acf5a72012bfd2e4
Autor:
Chih-Jen Wei, Wei Bu, Laura A. Nguyen, Joseph D. Batchelor, JungHyun Kim, Stefania Pittaluga, James R. Fuller, Hanh Nguyen, Te-Hui Chou, Jeffrey I. Cohen, Gary J. Nabel
Publikováno v:
Science Translational Medicine. 14
Epstein-Barr virus (EBV) is the major cause of infectious mononucleosis and is associated with several human cancers and, more recently, multiple sclerosis. Despite its prevalence and health impact, there are currently no vaccines or treatments. Four
Autor:
Yanfeng Zhou, Yu Qiu, Nicole Darricarrère, Masaru Kanekiyo, Adrian Creanga, Rebecca A. Gillespie, Syed M. Moin, Jacqueline Saleh, Jose Sancho, Te-Hui Chou, Ruijun Zhang, Shujia Dai, Anthony Moody, Kevin O. Saunders, Michelle C. Crank, John R. Mascola, Barney S. Graham, Chih-Jen Wei, Gary J. Nabel
Publikováno v:
Microscopy and Microanalysis. 27:2848-2850
Autor:
Chih-Jen Wei, Wei Bu, Laura A. Nguyen, Joseph D. Batchelor, JungHyun Kim, Stefania Pittaluga, James R. Fuller, Hanh Nguyen, Te-Hui Chou, Jeffrey I. Cohen, Gary J. Nabel
Epstein Barr virus (EBV) is the major cause of infectious mononucleosis and is associated with several human cancers. Despite its prevalence and major impact on human health, there are currently no specific vaccines or treatments. Four viral glycopro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4353c38ffbd8729ebfafd80a3dae4f04
https://doi.org/10.1101/2022.01.18.476774
https://doi.org/10.1101/2022.01.18.476774
Autor:
Jean Haensler, John R. Mascola, Thorsten U. Vogel, Ram Dharanipragada, Michael R. Reardon, Pradeep K. Dhal, Rebecca S. Rudicell, Barney S. Graham, Te-Hui Chou, Daniel Simard, Heather D. Kamp, Kanwen Yang, Joshua M. DiNapoli, Luis Z. Avila, Masaru Kanekiyo, Harry Kleanthous, Marie Garinot, Kurt Swanson, Lingyi Zheng, Xiaochu Duan, Chih-Jen Wei, Shujia Dai, Olivier Bedel, Rebecca A. Gillespie, Magnus Besev, Gary J. Nabel
Publikováno v:
Vaccine
Seasonal influenza vaccines represent a positive intervention to limit the spread of the virus and protect public health. Yet continual influenza evolution and its ability to evade immunity pose a constant threat. For these reasons, vaccines with imp
Autor:
Masaru Kanekiyo, Jose Sancho, Ruijun Zhang, John R. Mascola, Kevin O. Saunders, Gary J. Nabel, Anthony Moody, Barney S. Graham, Chih Jen Wei, Shujia Dai, Yanfeng Zhou, Jacqueline Saleh, Syed M. Moin, Adrian Creanga, Nicole Darricarrère, Michelle C. Crank, Te Hui Chou, Rebecca A. Gillespie, Yu Qiu
Publikováno v:
Science translational medicine. 13(583)
Seasonal influenza vaccines confer protection against specific viral strains but have restricted breadth that limits their protective efficacy. The H1 and H3 subtypes of influenza A virus cause most of the seasonal epidemics observed in humans and ar
Autor:
Harry Kleanthous, Thorsten U. Vogel, Gary J. Nabel, Ted M. Ross, Joshua M. DiNapoli, Rebecca S. Rudicell, Chih-Jen Wei, Te-Hui Chou, Svetlana Pougatcheva, Tim Alefantis, Xiaochu Duan, Nicole Darricarrère
Publikováno v:
Journal of Virology
Seasonal influenza vaccines elicit strain-specific immune responses designed to protect against circulating viruses. Because these vaccines often show limited efficacy, the search for a broadly protective seasonal vaccine remains a priority. Among di
Autor:
James Arthos, David C. Montefiori, Guangnan Hu, Yan Wang, Yuxin Chen, Shan Lu, Paul R. Clapham, Dong Han, Shuying Liu, Te-Hui Chou, Veronica Efros, Aaron Wallace, Anthony Hackett, Shixia Wang
Publikováno v:
Human Vaccines & Immunotherapeutics
Our previous preclinical studies and a Phase I clinical trial DP6-001 have indicated that a polyvalent Env formulation was able to elicit broadly reactive antibody responses including low titer neutralizing antibody responses against viral isolates o
Publikováno v:
Vaccine. 26:5145-5152
Hepatitis B Virus (HBV) infection remains a major worldwide infectious disease with serious long-term morbidity and mortality. The limited selections of drug treatment are not able to control the progress of disease in people with active and persiste
Autor:
Jonathan Tanguay, Shan Lu, Siyuan Shen, Innocent Mboudjeka, Te-Hui Chou, Arthur Chou, Zuhu Huang, Shixia Wang
Publikováno v:
Current HIV research. 6(4)
A good understanding about the structure and function of the envelope glycoprotein (Env) from primary human immunodeficiency virus-1 (HIV-1) isolates is important in facilitating the development of effective neutralizing antibody responses as a compo